Commonwealth Equity Services
FOLD

Commonwealth Equity Services’s Amicus Therapeutics FOLD Stock Holding History

Commonwealth Equity Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,717
Closed -$201K – 3421
2020
Q4 		$201K Buy
+8,717
New +$178K ﹤0.01% 2920
2019
Q4 		– Sell
-30,661
Closed -$245K – 2910
2019
Q3 		$245K Buy
30,661
+100
+0.3% +$1.08K ﹤0.01% 2412
2019
Q2 		$381K Sell
30,561
-200
-0.7% -$2.54K ﹤0.01% 2013
2019
Q1 		$418K Sell
30,761
-110
-0.4% -$1.34K ﹤0.01% 1897
2018
Q4 		$295K Sell
30,871
-890
-3% -$9.78K ﹤0.01% 2026
2018
Q3 		$383K Buy
31,761
+200
+0.6% +$2.8K ﹤0.01% 1978
2018
Q2 		$493K Sell
31,561
-25
-0.1% -$378 ﹤0.01% 1759
2018
Q1 		$475K Buy
31,586
+1,075
+4% +$16.4K ﹤0.01% 1747
2017
Q4 		$439K Sell
30,511
-50
-0.2% -$687 ﹤0.01% 1781
2017
Q3 		$461K Buy
+30,561
New +$404K ﹤0.01% 1672

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services's FOLD Position: Q1 2021 in Review

Commonwealth Equity Services sold out of Amicus Therapeutics (FOLD) in Q1 2021, closing a stake of 8,717 shares — an estimated $201K sold.

Commonwealth Equity Services first reported a position in FOLD in Q3 2017 and held it in 10 quarters. The position peaked at $493K in Q2 2018. 258 funds tracked by Wall St. Rank hold FOLD as of Q1 2021.

  • Commonwealth Equity Services reported no remaining Amicus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 8,717 Amicus Therapeutics shares in Q1 2021, an estimated $201K.
  • Commonwealth Equity Services first reported a position in Amicus Therapeutics in Q3 2017 and held it in 10 quarters.
  • Commonwealth Equity Services's Amicus Therapeutics position peaked at $493K in Q2 2018.
  • 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.